As water contaminants continue to evolve, regulatory agencies have responded with increasingly stringent testing methodologies. EPA Method 537.1, established by the Environmental Protection Agency, addresses the detection of specific per- and polyfluoroalkyl substances (PFAS) in drinking water. With PFAS often termed “forever chemicals” due to their persistence in the environment and human body, municipalities, engineers, and water treatment facilities face unprecedented challenges. This article equips professionals with the knowledge needed to effectively navigate Method 537.1 within the current regulatory and technological landscape. Choosing and working with a laboratory is covered in our guide to PFAS lab testing.
Scope, stated plainly: Method 537.1 is validated for drinking water only. It is not the method for wastewater, surface water, groundwater, soil, or biosolids; those matrices use EPA Method 1633. Using 537.1 on wastewater samples produces data that is not defensible for permit purposes.
EPA Method 537 was published in 2009, with a minor revision as version 1.1, and covered 14 PFAS. Method 537.1 was published in November 2018 and revised as version 2.0 in March 2020. It expanded the list to 18 compounds by adding four newer-generation PFAS, including HFPO-DA (the GenX chemical) and ADONA, reflecting the replacement chemistries industry had moved to after phasing out PFOA and PFOS. The urgency behind this enhancement stemmed from growing public concern and scientific evidence detailing the adverse health effects of PFAS exposure.
The primary aim of Method 537.1 is to detect 18 PFAS compounds in drinking water, including perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS). This method ensures that environmental agencies can effectively monitor water supplies, safeguarding public health and aligning with current regulatory demands.
Research consistently shows that PFAS exposure is linked to various health issues, including thyroid disorders, immune system dysfunction, and certain cancers. A comprehensive analysis conducted by the National Toxicology Program highlighted that even low levels of PFAS can be detrimental to health, emphasizing the need for robust testing methodologies like Method 537.1.
In recent years, federal and state regulations have tightened around PFAS detection and reporting. The EPA’s commitment to holding water suppliers accountable necessitates the use of Method 537.1, ensuring compliance with regulatory standards such as the Safe Drinking Water Act.
The efficacy of PFAS detection relies heavily on proper sample collection techniques. Samples are collected in 250 mL polypropylene bottles supplied by the laboratory and pre-loaded with Trizma, which both buffers the sample and removes free chlorine. Samples must be chilled during shipment and kept at or below 6°C in the laboratory. The holding time is 14 days from collection to extraction, not to analysis; extracts may then be held up to 28 days before instrumental analysis. Field reagent blanks are required to detect contamination introduced during sampling.
Method 537.1 employs solid-phase extraction (SPE) on a styrene-divinylbenzene sorbent followed by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Quantitation uses internal standards rather than full isotope dilution, which is one of the key differences from Method 533. This dual approach allows for the sensitive detection of low-concentration PFAS compounds. Industry advancements in mass spectrometry have significantly enhanced detection limits, with current capabilities reaching parts per trillion (ppt) levels.
To ensure validity, Method 537.1 mandates rigorous quality control checks, including method blanks, fortified blanks, and duplicate samples. These measures guarantee that the data produced is reliable and defensible.
Method 537.1 is performed by certified laboratories, not by treatment plant staff. The operator’s role is sample collection, and that is where most avoidable errors occur: contamination from PTFE-containing equipment, waterproof clothing, or personal care products; missing field reagent blanks; and samples arriving outside temperature or holding-time limits. Good chain-of-custody records support compliance audits.
States that set PFAS drinking water limits ahead of the federal rule, including Massachusetts, relied on Method 537.1 data to identify systems needing treatment. Specific outcomes should be taken from the state agency’s own published reports.
The integration of Method 537.1 has prompted advancements in water treatment technologies. Facilities are investing in treatment capable of removing PFAS: granular activated carbon, PFAS-selective ion exchange, and reverse osmosis. Advanced oxidation is not among them, since conventional AOPs do not break the carbon-fluorine bond.
Despite its advancements, Method 537.1 faces challenges related to the detection of all PFAS variants. Some emerging PFAS may not be included in the current methodology, stressing the need for continued updating and validation of testing procedures.
Innovations in analytical technology are emerging to address limitations. Techniques such as high-resolution mass spectrometry (HRMS) are being explored to broaden the scope of detectable contaminants beyond those specified in Method 537.1.
Method 537.1 is not the only approved drinking water method. EPA Method 533, published in 2019, covers 25 PFAS using weak anion exchange extraction and isotope dilution quantitation, and recovers short-chain compounds better. Both methods are approved for compliance monitoring under the 2024 drinking water rule; together they cover 29 unique PFAS, and many laboratories run both. For a broader view of where each fits, see our guide to PFAS analytical methods, and for lower-cost approaches suited to initial surveys, our article on PFAS screening methods.
Method 537.1 is a targeted PFAS method and will not expand to cover unrelated contaminants such as microplastics, which require entirely different analytical techniques. Broader PFAS coverage is being addressed through additional methods, such as 533 and 1633, and through non-targeted approaches such as total organic fluorine analysis. Ongoing research initiatives underscore the need for adaptable testing practices in water quality management.
As public awareness of water quality increases, regulatory bodies are expected to impose stricter guidelines. The ongoing development and refinement of Method 537.1 will be pivotal in ensuring that water suppliers can meet these standards.
EPA Method 537.1 is a critical framework for the detection of PFAS in drinking water, significantly impacting public health and environmental security. By understanding its applications, challenges, and future directions, professionals within the water treatment sector can better equip themselves to respond to the evolving regulatory landscape and protect community health. As we look to the future, continuous adaptation and innovation in methodologies will remain crucial in addressing emerging threats to our water supplies.
Through persistent vigilance and adherence to updated regulatory practices, we can safeguard our most vital resource—clean, safe drinking water.